Ra Capital Management, L.P. Arcellx, Inc. Transaction History

Ra Capital Management, L.P.

$5.82 Billion
Q3 2025

A detailed history of Ra Capital Management, L.P. transactions in Arcellx, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,036,527 shares of ACLX stock, worth $273 Million. This represents 4.28% of its overall portfolio holdings.

Number of Shares

3,036,527

Previous 3,036,527 -0.0%

Holding current value

$273 Million

Previous $200 Million 24.68%

% of portfolio

4.28%

Previous 4.37%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$60.26 - $79.13 $15 Million - $19.7 Million	249,200 Added 8.94%	3,036,527 $199 Million
Q4 2024 Feb 14, 2025	BUY	$75.39 - $106.53 $70.6 Million - $99.7 Million	935,848 Added 50.55%	2,787,327 $212 Million
Q3 2024 Nov 14, 2024	BUY	$50.91 - $86.61 $12.6 Million - $21.4 Million	247,465 Added 15.43%	1,851,479 $155 Million
Q2 2024 Aug 14, 2024	BUY	$49.74 - $66.98 $79.8 Million - $107 Million	1,604,014 New	1,604,014 $88.5 Million

About Arcellx, Inc.

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.94B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

More about ACLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Account

Ra Capital Management, L.P. Arcellx, Inc. Transaction History